Joseph T. Schepers
No más puestos en curso
Perfil
Joseph T.
Schepers held several positions in investor relations and communications, including Director of Investor Relations at Shionogi Pharma, Director of Investor Relations at Novartis AG, and Executive Director of Investor Relations and Corporate Communications at Chimerix, Inc. He also served as Vice President of Corporate Communications at Artivion, Inc. and Vice President of Investor Relations at Aravive, Inc. Prior to these roles, he was the VP of Corporate Communications and Investor Relations at Bausch Health Americas, Inc. from 2000 to 2003.
Schepers earned an undergraduate degree and an MBA from Seton Hall University.
Antiguos cargos conocidos de Joseph T. Schepers.
Empresas | Cargo | Fin |
---|---|---|
CHIMERIX, INC. | Contacto de Relaciones con Inversores | - |
PERNIX THERAPEUTICS HOLDINGS INC | Contacto de Relaciones con Inversores | 01/01/2013 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Public Communications Contact | 01/01/2003 |
ARAVIVE, INC. | Contacto de Relaciones con Inversores | - |
NOVARTIS AG | Consejero General | - |
Formación de Joseph T. Schepers.
Seton Hall University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
ARTIVION, INC. | Health Technology |
NOVARTIS AG | Health Technology |
CHIMERIX, INC. | Health Technology |
ARAVIVE, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Pernix Therapeutics Holdings, Inc.
Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
- Bolsa de valores
- Insiders
- Joseph T. Schepers